UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate

Gastroenterology (New York, N.Y. 1943), 2013-12, Vol.145 (6), p.1334-1346.e11

2013

Volltextzugriff (PDF)

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit

European journal of pharmacology, 2010-12, Vol.649 (1), p.328-335

2010

Volltextzugriff (PDF)

Experimentally Induced Bladder Permeability Evokes Bladder Afferent Hypersensitivity in the Absence of Inflammation

Frontiers in neuroscience, 2020-10, Vol.14, p.590871-590871

2020

Volltextzugriff (PDF)

Linaclotide activates guanylate cyclase‐C/cGMP/protein kinase‐II‐dependent trafficking of CFTR in the intestine

Physiological reports, 2017-06, Vol.5 (11), p.e13299-n/a

2017

Volltextzugriff (PDF)

A Methionine Aminopeptidase-2 Inhibitor, PPI-2458, for the Treatment of Rheumatoid Arthritis

Proceedings of the National Academy of Sciences - PNAS, 2004-07, Vol.101 (29), p.10768-10773

2004

Volltextzugriff (PDF)

EP1238: COLORECTAL NOCICEPTIVE PROCESSING IN THE CAUDAL VENTROLATERAL MEDULLA AND THE LATERAL PARABRACHIAL NUCLEI IS INCREASED IN A MOUSE MODEL OF CHRONIC VISCERAL HYPERSENSITIVITY AND IS REVERSED BY CHRONIC LINACLOTIDE TREATMENT

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1074-S-1075

2022

Volltextzugriff (PDF)

Guanylate cyclase 2C agonism corrects CFTR mutants

JCI insight, 2017-10, Vol.2 (19)

2017

Volltextzugriff (PDF)

Su134 INTRACOLONIC ADMINISTRATION OF LINACLOTIDE RELIEVES VISCERAL HYPERSENSITIVITY BY INHIBITING CHRONIC PSYCHOLOGICAL STRESS-INDUCED ACTIVATION OF CENTRAL NOCICEPTIVE PATHWAYS IN RATS

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-629-S-630

2021

Volltextzugriff (PDF)

Su136 COLORECTAL NOCICEPTIVE PROCESSING IN THE ROSTRAL VENTROMEDIAL AND CAUDAL VENTROLATERAL MEDULLA IS INCREASED IN A MOUSE MODEL OF CHRONIC VISCERAL HYPERSENSITIVITY AND IS REVERSED BY CHRONIC LINACLOTIDE TREATMENT

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-630-S-630

2021

Volltextzugriff (PDF)

Su1220 ATTENUATION OF STRESS-INDUCED ACTIVATION OF SUPRASPINAL PAIN CIRCUITS CONTRIBUTES TO ANTI-NOCICEPTIVE EFFECTS OF LINACLOTIDE

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-548-S-548

2020

Volltextzugriff (PDF)

EP1239: DESCENDING PAIN MODULATION OF COLORECTAL NOCICEPTIVE PROCESSING IN THE SPINAL CORD IS IMBALANCED IN A MOUSE MODEL OF POST-COLITIS CHRONIC VISCERAL HYPERSENSITIVITY AND IS REDUCED BY CHRONIC ORAL LINACLOTIDE TREATMENT

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1075

2022

Volltextzugriff (PDF)

240: COLON-TARGETED DELIVERY OF GUANYLATE CYCLASE-C AGONIST IW-3300 RELIEVES COMORBID CHRONIC PELVIC AND SOMATIC PAIN IN A RAT MODEL OF EARLY LIFE STRESS-INDUCED COLONIC HYPERSENSITIVITY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-48-S-48

2022

Volltextzugriff (PDF)

Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain

Trends in pharmacological sciences (Regular ed.), 2022-02, Vol.43 (2), p.110-122

2022

Volltextzugriff (PDF)

Mo1515 - Bile Acid Sequestrant Shows Effects on the Contractile Activity of Ex Vivo Lower Esophageal Sphincter Muscle

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-736-S-736

2018

Volltextzugriff (PDF)

1017 - Guanylate Cyclase 2C Activation Rescues the Folding Defect in F508Del CFTR

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-193-S-193

2018

Volltextzugriff (PDF)

Linaclotide treatment reduces endometriosis-associated vaginal hyperalgesia and mechanical allodynia through viscerovisceral cross-talk

Pain (Amsterdam), 2019-11, Vol.160 (11), p.2566-2579

2019

Volltextzugriff (PDF)

Mo1146 CHRONIC INTRA-COLONIC LINACLOTIDE ADMINISTRATION ALTERS GLIAL ACTIVATION IN A MOUSE MODEL OF CHRONIC VISCERAL HYPERSENSITIVITY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-803-S-803

2020

Volltextzugriff (PDF)

Sa1677 – Chronic Colonic Administration of the Guanylate Cyclase-C Agonist Linaclotide Attenuates Colitis Induced Bladder Afferent Hyperactivity

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-363-S-363

2019

Volltextzugriff (PDF)

Peripheral Guanylate Cyclase‐C modulation of corticolimbic activation and corticotropin‐releasing factor signaling in a rat model of stress‐induced colonic hypersensitivity

Neurogastroenterology and motility, 2021-03, Vol.33 (3), p.e14076-n/a

2021

Volltextzugriff (PDF)

Su1578 – Chronic Intracolonic Administration of Linaclotide Inhibits Nociceptive Signaling in a Mouse Model of Chronic Visceral Hypersensitivity

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-570-S-570

2019

Volltextzugriff (PDF)

A Novel Methionine Aminopeptidase-2 Inhibitor, PPI-2458, Inhibits Non–Hodgkin's Lymphoma Cell Proliferation In vitro and In vivo

Clinical cancer research, 2006-04, Vol.12 (8), p.2583-2590

2006

Volltextzugriff (PDF)

Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation

The Journal of pharmacology and experimental therapeutics, 2013-01, Vol.344 (1), p.196

2013

Volltextzugriff (PDF)

Oral Administration of the Gut-Restricted Guanylate Cyclase-C Agonist, Linaclotide, Reduces Endometriosis-Induced Vaginal Hyperalgesia

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S711

2017

Volltextzugriff (PDF)

Mo1541 - Oral Administration of the Gut-Restricted Guanylate Cyclase-C Agonist, Linaclotide, Reduces Endometriosis-Induced Vaginal Hyperalgesia

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S711-S711

2017

Volltextzugriff (PDF)

Tu1602 - Linaclotide Attenuates Visceral Organ Crosstalk: Importance of Guanylate Cyclase C (GC-C) Activation in Reversing Colonic Hypersensitivity Induced by Urinary Bladder Hyperpermeability

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S914-S914

2017

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(79)
Buchkapitel
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(35)
Animals
(26)
Humans
(21)
Biological And Medical Sciences
(17)
Female
(12)
Male
(11)
Medical Sciences
(10)
Gastroenterology And Hepatology
(9)
Mice
(9)
Pharmacology & Pharmacy
(9)
Biochemistry & Molecular Biology
(7)
Dose-Response Relationship, Drug
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Linaclotide
(7)
Molecular Sequence Data
(7)
Peptides - Pharmacology
(7)
Rats
(7)
Aminopeptidases - Antagonists & Inhibitors
(6)
Base Sequence
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit

Experimentally Induced Bladder Permeability Evokes Bladder Afferent Hypersensitivity in the Absence of Inflammation

Linaclotide activates guanylate cyclase‐C/cGMP/protein kinase‐II‐dependent trafficking of CFTR in the intestine

A Methionine Aminopeptidase-2 Inhibitor, PPI-2458, for the Treatment of Rheumatoid Arthritis

EP1238: COLORECTAL NOCICEPTIVE PROCESSING IN THE CAUDAL VENTROLATERAL MEDULLA AND THE LATERAL PARABRACHIAL NUCLEI IS INCREASED IN A MOUSE MODEL OF CHRONIC VISCERAL HYPERSENSITIVITY AND IS REVERSED BY CHRONIC LINACLOTIDE TREATMENT

Guanylate cyclase 2C agonism corrects CFTR mutants

Su134 INTRACOLONIC ADMINISTRATION OF LINACLOTIDE RELIEVES VISCERAL HYPERSENSITIVITY BY INHIBITING CHRONIC PSYCHOLOGICAL STRESS-INDUCED ACTIVATION OF CENTRAL NOCICEPTIVE PATHWAYS IN RATS

Su136 COLORECTAL NOCICEPTIVE PROCESSING IN THE ROSTRAL VENTROMEDIAL AND CAUDAL VENTROLATERAL MEDULLA IS INCREASED IN A MOUSE MODEL OF CHRONIC VISCERAL HYPERSENSITIVITY AND IS REVERSED BY CHRONIC LINACLOTIDE TREATMENT

Su1220 ATTENUATION OF STRESS-INDUCED ACTIVATION OF SUPRASPINAL PAIN CIRCUITS CONTRIBUTES TO ANTI-NOCICEPTIVE EFFECTS OF LINACLOTIDE

EP1239: DESCENDING PAIN MODULATION OF COLORECTAL NOCICEPTIVE PROCESSING IN THE SPINAL CORD IS IMBALANCED IN A MOUSE MODEL OF POST-COLITIS CHRONIC VISCERAL HYPERSENSITIVITY AND IS REDUCED BY CHRONIC ORAL LINACLOTIDE TREATMENT

240: COLON-TARGETED DELIVERY OF GUANYLATE CYCLASE-C AGONIST IW-3300 RELIEVES COMORBID CHRONIC PELVIC AND SOMATIC PAIN IN A RAT MODEL OF EARLY LIFE STRESS-INDUCED COLONIC HYPERSENSITIVITY

Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain

Mo1515 - Bile Acid Sequestrant Shows Effects on the Contractile Activity of Ex Vivo Lower Esophageal Sphincter Muscle

1017 - Guanylate Cyclase 2C Activation Rescues the Folding Defect in F508Del CFTR

Linaclotide treatment reduces endometriosis-associated vaginal hyperalgesia and mechanical allodynia through viscerovisceral cross-talk

Mo1146 CHRONIC INTRA-COLONIC LINACLOTIDE ADMINISTRATION ALTERS GLIAL ACTIVATION IN A MOUSE MODEL OF CHRONIC VISCERAL HYPERSENSITIVITY

Sa1677 – Chronic Colonic Administration of the Guanylate Cyclase-C Agonist Linaclotide Attenuates Colitis Induced Bladder Afferent Hyperactivity

Peripheral Guanylate Cyclase‐C modulation of corticolimbic activation and corticotropin‐releasing factor signaling in a rat model of stress‐induced colonic hypersensitivity

Su1578 – Chronic Intracolonic Administration of Linaclotide Inhibits Nociceptive Signaling in a Mouse Model of Chronic Visceral Hypersensitivity

A Novel Methionine Aminopeptidase-2 Inhibitor, PPI-2458, Inhibits Non–Hodgkin's Lymphoma Cell Proliferation In vitro and In vivo

Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation

Oral Administration of the Gut-Restricted Guanylate Cyclase-C Agonist, Linaclotide, Reduces Endometriosis-Induced Vaginal Hyperalgesia

Mo1541 - Oral Administration of the Gut-Restricted Guanylate Cyclase-C Agonist, Linaclotide, Reduces Endometriosis-Induced Vaginal Hyperalgesia

Tu1602 - Linaclotide Attenuates Visceral Organ Crosstalk: Importance of Guanylate Cyclase C (GC-C) Activation in Reversing Colonic Hypersensitivity Induced by Urinary Bladder Hyperpermeability

Suchergebnisse filtern